Bin Xu

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

55h-index11.0kcitations630works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Cancer Diagnosis and Treatment(94), Nutrition, Genetics, and Disease(72), Ovarian cancer diagnosis and treatment(59), Virus-based gene therapy research(58), Salivary Gland Tumors Diagnosis and Treatment(53)

Publications629 total

Supplementary Table 6 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table and Figure Legends from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Figure 4 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table 4 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table 2 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table 7 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table 5 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Figure 1 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
Supplementary Table 1 from Telomerase Upregulation Induces Progression of Mouse Braf<sup>V600E</sup>-Driven Thyroid Cancers and Triggers Nontelomeric Effects
2025Open Access
<scp>DIA</scp> Regimen Versus <scp>IA</scp> Regimen for Induction Therapy in Younger Adults With Acute Myeloid Leukemia: A Multicenter Open‐Label Randomized Controlled Trial
American Journal of Hematology·2025Open Access
Intra-tumoral microbiota: Key modulators of tumor immunity and therapeutic potential
Genes & Diseases·2025Open Access
SH2B3 expression predicts selinexor sensitivity in acute myeloid leukemia
Blood·2025
The prognostic impact of blood vessel invasion in infiltrative papillary thyroid carcinoma: a retrospective case–control study
Histopathology·2025
Fenestrating Adenocarcinoma
The American Journal of Surgical Pathology·2025
Pathologic Response to Neoadjuvant Cetuximab, Platinum, and Taxane in Locally Advanced HNSCC
Otolaryngology·2025Open Access
Multifocality in sporadic medullary thyroid carcinoma is associated with low tumor grade and no difference in somatic driver mutations or overall survival when compared with unifocal tumors
Surgery·2025
Pathological Diagnosis of Thyroid Nodules with Preoperatively Detected <i>TERT</i> Promoter Mutations in the Absence of <i> BRAF <sup>V600E</sup> </i> : A Bi-Center Series of 52 Cases
Thyroid·2025
635eP The necessity of adding anti-HER2 antibody to TKI in trastuzumab-resistant, HER2-positive ABC: A multicenter real-world study
Annals of Oncology·2025Open Access
Loss of tumor cell MHC class II drives MAPK inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers
Journal of Clinical Investigation·2025Open Access
Tumors of the Thyroid and Parathyroid Glands
American Registry of PathologyArlington, Virginia eBooks·2025
page 1 of 32Next →

Frequent Co-authors

Ronald Ghossein(28), Nora Katabi(17), Ian Ganly(15), R. Michael Tuttle(11), Snjezana Doğan(9), James A. Fagin(6), Jocelyn Migliacci(5), Cristina R. Antonescu(5), Iñigo Landa(4), Jeffrey A. Knauf(4), Michael F. Berger(4), Margaret Fahnestock(4), Richard J. Wong(4), Snehal G. Patel(4), Achim A. Jungbluth(4), Giovanni Tallini(4), Tihana Ibrahimpašić(3), Eric J. Sherman(3), Narasimhan P. Agaram(3), Sumit Middha(3)